secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-211545
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health gets Nasdaq extension to May 18 for bid-price compliance; delisting risk remains
--------------------------------------------------------------------------------

- Received Nasdaq Staff notice on May 1, 2026 for non-compliance with 500,000 publicly held shares requirement.
- Investors exercised pre-funded warrants on May 4, 2026, curing publicly held shares deficiency.
- Panel granted one-day extension to May 18, 2026 to show closing bid price >= $1.00 for 10 consecutive days.
- Company warns it may not meet the extension terms and could face delisting from Nasdaq.
- Non-compliance with bid price rule clock reset after cure of publicly held shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526211545/0001193125-26-211545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526211545/d55784d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-211545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer